Диссертация (1173229), страница 26
Текст из файла (страница 26)
Bone health in cystic fibrosis: use146of oral bisphosphonates // Lancet Respir. Med., 2013, Vol. 1, № 5, P. 349 – 350.307. Lee J.K., Kim K.W., Choi J.Y., Moon S.Y., Kim S.G. et al. Bisphosphonates-related osteonecrosis of the jaw in Korea: a preliminary report // J. Korean.Assoc.
Oral. Maxillofac. Surg., 2013, Vol. 39, № 1, P. 9 – 13.308. Lee J.Y., Lee Y.M., Shin S.Y., Seol Y.J., Ku Y., Rhyu I.C., Chung C.P.,Han S.B. Effect of subantimicrobial dose doxycycline as an effective adjunct toscaling and root planning // J. Periodontol., 2004, Vol. 75, Р. 1500 – 1508.309. Li R., Tian C., Postlethwaite A., Jiao Y., Garcia-Godoy F., Pattanaik D.,Wei D., Gu W., Li J. Rheumatoid arthritis and periodontal disease: What are thesimilarities and differences? // Int.
J. Rheum. Dis., 2017, Vol. 20(12), P. 1887 –1901.310. Longato L., Cavalli L., Marcucci G. et al. Osteonecrosis of the jaw in a patient with rheumatoid arthritis treated with an oral aminobisphosphonate: a clinicalcase report // Clin. Cases Miner. Bone Metab., 2013, Vol.
10, № 2, P. 139 – 141.311. López-Cedrún J.L., Sanromán J.F., García A. et al. Oral bisphosphonaterelated osteonecrosis of the jaws in dental implant patients: a case series // Br.J. Oral Maxillofac. Surg., 2013, Vol., № 8, Р. 874 – 879.312. Mellins E.D., Macaubas C., Grom A.A. Pathogenesis of systemic juvenileidiopathic arthritis: some answers, more questions // Nature rev.
Rheumat., 2011,Vol. 7, № 7, P. 416 – 426.313. Mercado F.B., Marshall R.I., Bartold P.M. Inter-relationships betweenrheumatoid arthritis and periodontal disease. A review // J. Clin. Periodontol.,2003, Vol. 30, № 9, P. 761 – 772.314. Mercado F.B., Marshall R.I., Klestov A.C., Bartold P.M. Relationship between rheumatoid arthritis and periodontitis // J.
Periodontol., 2001, Vol. 72, № 6,P. 779 – 787.315. Mercado F.B., Marshall R.L, Klestov A.C., Bartold P.M. Is there a relationship between rheumatoid arthritis and periodontal disease? // J. Clin. Periodontol.,2000, Vol.27, № 4, P .267 – 272.147316. Miranda L.A., Braga F.5 Fischer R.G., Sztajnbok F.R., Figueredo СМ.,Gustafsson A. Changes in periodontal and rheumatological conditions after 2 yearsin patients with juvenile idiopathic arthritis // J. Periodontol., 2006, Vol.
77, №10. P. 1695 – 1700.317. Miranda L.A., Fischer R.G., Sztajnbok F.R., Figueredo СМ., Gustafsson A.Periodontal conditions in patients with juvenile idiopathic arthritis // J. Clin.Periodontol., 2003, Vol. 30, № 11, P. 969 – 974.318. Moeini M., Moeini M., Lotfizadeh N., Alavi M.
Radiography finding in thejaws in children taking bisphosphonate // Iran J. Ped. Hematol. Oncol., 2013, Vol.3, № 3, P. 114 – 118.319. Moen K., Bran J.G., Valen M., Skartveit L., Eribe E.K., Olsen I., Jonsson R.Synovial inflammation in active rheumatoid arthritis and psoriatic arthritis facilitates trapping of a variety of oral bacterial DNAs // Clin.
Exp. Rheumatol., 2006,Vol. 24, № 6, P. 656 – 663.320. Nanbara H., Wara-aswapati N., Nagasawa T. et al. Modulation of Wnt5aexpression by periodontopathic bacteria // PLoS One., 2012, Vol. 7, № 4, e34434.321. Needleman I., Suvan J., Gilthorpe M.S. et al. A randomized-controlled trialof low-dose doxycycline for periodontitis in smokers // J. Clin. Periodont., 2007,Vol. 34, № 4, P.
325 – 333.322. Ngan K.K., Bowe J., Goodger N. The risk of bisphosphonate-related osteonecrosis of the jaw in children. A case report and literature review // Dent. Update., 2013, Vol. 40, № 9, P. 733 – 734.323. Novak M.J., Johns L.P., Miller R.C., Bradshaw M.H. Adjunctive benefits ofsubantimicrobial dose doxycycline in the management of severe, generalized,chronic periodontitis // J.
Periodontol., 2002, Vol. 73, P. 762 – 769.324. Oates T.W., Graves D.T., Cochran D.L. Clinical, radiographic and biochemical assessment of IL-1 / TNF-alpha antagonist inhibition of bone loss in experimental periodontitis // J. Clin. Periodontol., 2002, Vol.
29, Р. 137 – 143.325. Ogrendik M., Kokino S., Ozdemir F., Bird P.S., Hamlet S. Serum antibodies148to oral anaerobic bacteria in patients with rheumatoid arthritis // Med. Gen. Med.,2005, Vol. 7, № 2, P. 2 – 6.326. Otto S., Pautke C., Hafner S. et al. Pathologic fractures in bisphosphonaterelated osteonecrosis of the jaw-review of the literature and review of our own cases // Craniomaxillofac.
Trauma Reconstr., 2013, Vol. 6, № 3, Р. 147 – 154.327. Özçaka Ö., Alpöz E., Nalbantsoy A., Karabulut G., Kabasakal Y. Clinicalperiodontal status and inflammatory cytokines in primary Sjögren syndrome andrheumatoid arthritis // J. Periodontol., 2018, Vol. 89(8), P. 959 – 965.328. Paiva-Fonseca F., Santos-Silva A.R., Della-Coletta R., Vargas P.A., LopesM.A.
Alendronate-associated osteonecrosis of the jaws: A review of the main topics // Med. Oral Patol. Oral Ci.r Bucal., 2014, Vol. 19, № 2, Р. e106 – 111.329. Patel B.P., Rawal U.M., Dave T.K. et all. Lipid peroxidation, total antioxidant status, and total thiol levels predict overall survival in patients with oralsquamous cell carcinoma // Integr. Cancer Ther., 2007, Vol. 6, № 4, P. 365 – 372.330. Paul B.J., Kandy H.I., Krishnan V. Pre-rheumatoid arthritis and its prevention // Eur. J.
Rheumatol., 2017, Vol. 4, № 2, P. 161 – 165.331. Pazianas M., Abrahamsen B., Ferrari S., Russell R.G. Eliminating the needfor fasting with oral administration of bisphosphonates // Ther. Clin. Risk.Manag., 2013, Vol. 9, P. 395 – 402.332. Pedersen B., Kelly D.L., Tree J.A., et al. Doxycycline and HIV-infectionsuppress tuberculosis-induced matrix metalloproteinases // Am. J. Respir.
Crit.Care Med., 2012, Vol. 185, № 9, Р. 989 – 997.333. Persson G.R. Rheumatoid arthritis and periodontitis – inflammatory and infectious connections. Review of the literature [Электронный ресурс] / [et al.] //Journal of Oral Microbiology. – 2012. – Vol. 4. – Режим доступа:doi:10.3402/jom.v4i0.11829334. Pichardo S.E., van Merkesteyn J.P. Bisphosphonate related osteonecrosis ofthe jaws: spontaneous or dental origin? // Oral Surg., 2013, Vol.
116, № 3, P. 287 –292.149335. Plessas A. Nonsurgical periodontal treatment: review of the evidence / OralHealth Dent. Manag., 2014, Vol. 13, № 1, Р. 71 – 80.336. Prakasam A., Elavarasu S.S., Natarajan R.K. Antibiotics in the managementof aggressive periodontitis // J. Pharm. Bioallied. Sci., 2012, Vol. 4 (Suppl 2), Р.S252 – 255.337. PreshawP.M.Host response modulation inperiodontics//Periodontol., 2008, Vol. 48, Р. 92 – 110.338. Preshaw P.M., Hefti A.F., Jepsen S. et al. Subantimicrobial dose doxycycline as adjunctive treatment for periodontitis.
A review // J. Clin. Periodontol.,2004, 31, P. 697 – 707.339. Preshaw P.M., Hefti A.F., Novak M.J. et al. Subantimicrobial dose doxycycline enhances the efficacy of scaling and root planning in chronic periodontitis: amulticenter trial // J. Periodontol., 2004, Vol. 75, Р. 1068 – 1076.340. Preshaw P.M., Novak M.J., Mellonig J. Modified release subantimicrobialdose doxycycline enhances scaling and root planning in subjects with periodontalDisease // J. Periodontol., 2008, Vol. 79, № 3, P.
440 – 452.341. Price U., Le H.O.,Powell S.E. et al. Effects of local simvastatin-alendronateconjugate in preventing periodontitis bone loss // J. Periodontal. Res., 2013, Vol.48, № 5, P. 541 – 548.342. Radominski S.C., Cardiel M.H., Citera G., Goecke A. et al. Tofacitinib, anoral Janus kinase inhibitor, for the treatment of Latin American patients withrheumatoid arthritis: Pooled efficacy and safety analyses of Phase 3 and long-termextension studies // Reumatol.
Clin., 2016, S1699.343. Ramamurthy N.S., Greenwald R.A., Celiker M.Y., Shi E.Y. Experimentalarthritis in rats induces biomarkers of periodontitis which are ameliorated by genetherapy with tissue inhibitor of matrix metalloproteinases // J. Periodontol., 2005,Vol. 76, № 2, P. 229 – 233.344. Reddy M.S., Weatherford T.W., Smith C.A.
et al. Alendronate treatment ofnaturally occurring periodontitis in beagle dogs // J. Periodontol., 2001, Vol. 66, Р.150211 – 217.345. Reichert S., Machulla H.K., Fuchs C, John V., Schaller H.G., Stein J. Isthere a relationship between juvenile idiopathic arthritis and periodontitis? // J. Clin.Periodontol., 2006, Vol. 33, № 5, P. 317 – 323.346. Reichert S., Stein J., Fuchs C, John V., Schaller H.G., Machulla H.K.
Arethere common human leucocyte antigen associations in juvenile idiopathic arthritisand periodontitis? // J. Clin. Periodontol., 2007, Vol. 34, № 6, P. 492 – 498.347. Repeke C.E., Ferreira S.B.Jr., Vieira A.E. et al. Dose-response metRANTES treatment of experimental periodontitis: a narrow edge between the disease severity attenuation and infection control // PLoS One., 2011, Vol. 6, № 7,e22526.348. Ribeiro J., Legjo A., Novaes A.B. Periodontal infection as a possible severity factor for rheumatoid arthritis // J. Clin. Periodontol., 2005, Vol.
32, № 4, P. 412–416.349. Rigante D. The etiology of juvenile idiopathic arthritis // Clin. Rev. Allergy& Immunology., 2015, Vol. 49, № 2, P. 253 – 261.350. Ristow O., Gerngroß C., Schwaiger M. et al. Effect of antiresorptive drugson bony turnover in the jaw: denosumab compared with bisphosphonates // Br.J. Oral. Maxillofac.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
